Cite
HARVARD Citation
Dubash, S. et al. (n.d.). AB0846 Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost effective strategy in spondyloarthritis. Annals of the rheumatic diseases. pp. 1551-1552. [Online].